GlassScriptPhysician profile
Meredith L Riddle
NPI 1265870778
$2,802.76
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,103 · 2020: $713 · 2021: $516 · 2023: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $828.87 | 2019-2023 | Farxiga |
| Novo Nordisk INC | $598.84 | 2019-2021 | |
| Glaxosmithkline, LLC. | $231.10 | 2023 | Shingrix, Bexsero |
| Amgen INC. | $181.12 | 2019-2021 | |
| Lilly USA, LLC | $171.25 | 2019-2020 | |
| Ibsa Pharma INC. | $125.00 | 2021 | |
| Vivus LLC | $124.97 | 2023 | Qsymia |
| Sanofi Pasteur INC. | $90.04 | 2019 | |
| Sanofi-Aventis U.S. LLC | $71.92 | 2019 | |
| Amarin Pharma, INC. | $60.55 | 2019-2020 | |
| Pfizer INC. | $52.74 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.81 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $28.39 | 2019 | |
| Zyla Life Sciences, INC. | $24.33 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.21 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.81 | 2020 | |
| Lupin INC. | $16.53 | 2020 | |
| Abbvie INC. | $16.04 | 2021 | |
| Horizon Therapeutics Plc | $14.77 | 2020 | |
| Daiichi Sankyo INC. | $13.78 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.36 | 2020 | |
| Merck Sharp & Dohme LLC | $13.26 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.06 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.00 | 2019 | |
| Bausch Health US, LLC | $12.77 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Riddle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.